Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.
A news release from Benzinga shares that biotechnology company Emerald Health Pharmaceuticals is beginning a Phase 2 clinical study on EHP-101 as a treatment for patients with systemic sclerosis.…
Continue ReadingEmerald Health Pharmaceuticals Initiates Phase 2 Clinical Study on Systemic Sclerosis
According to a study summarized in Gastroenterology Consultant, pregnant women with intrahepatic cholestasis of pregnancy are much more likely to also be diagnosed with nonalcoholic fatty liver disease. You can…
Continue ReadingIntrahepatic Cholestasis of Pregnancy and its Link to Non-Alcoholic Fatty Liver Disease
As initially covered by MyLondon News, the family of a London boy with spinal muscular atrophy (SMA) is looking to advocate for others with this genetic disorder. Additionally, they…
Continue Reading“The Toddler that Doesn’t Toddle:” Raising a Child with Spinal Muscular Atrophy
According to a release on Public News Service, the state of West Virginia just implemented a new bipartisan law to support individuals with rare diseases and their families, a particular…
Continue ReadingRare Disease Advisory Council Formed in West Virginia
When some people hear "placebo effect," it conjures up images of sugar pills designed to stimulate patient belief. But according to Healio, the term has a different meaning in…
Continue ReadingThe Placebo Effect and Positive Patient Outcomes
According to a press release from the Boston Children's Hospital, a study has discovered the efficacy of CRISPR-Cas9 gene-editing technology in the treatment of facioscapulohumeral muscular dystrophy (FSHD). As…
Continue ReadingCRISPR as a Tool to Treat Facioscapulohumeral Muscular Dystrophy
According to a press release on Global Newswire, Novartis has received a positive opinion on Cosentyx® from the Committee for Medicinal Products for Human Use (CHMP). This positive opinion…
Research findings can sometimes come from unexpected places. For example, according to Parkinson's News Today, the benefits and shortcomings of an investigative gene therapy were explored through the post-mortem analysis…
Continue ReadingPost Mortem Gene Therapy Suggests Hopeful Results for Parkinson’s Disease Treatment
People across the globe are experiencing an unprecedented time of uncertainty as COVID-19 continues to spread. However, this pandemic has also brought about something wonderful: people stepping up to…
Continue ReadingCan You Donate Blood with a Lyme Disease Diagnosis?
As stated in a press release from the University of Illinois at Urbana-Champaign, researchers have discovered a bacterial protein fragment that is destructive to lung tissue. This can rapidly…
Continue ReadingIdiopathic Pulmonary Fibrosis Exacerbated by Bacterial Protein Fragment, Study Finds
Sourced from: Nephron / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)
According to a press release from FirstWord Pharma, Gen and Alnylam Pharmaceuticals have signed an exclusive distribution deal in Turkey for RNAi therapeutic ONPATTRO. This therapy drug will treat…
Continue ReadingExclusive Distribution Agreement in Turkey for ONPATTRO to Treat Hereditary ATTR Amyloidosis
Want to learn more about recognizing symptoms and diagnosing patients? Well, now you can. In a MedPage article, authors encourage readers to follow along on a case study to…
Continue ReadingUncovering the Cause of Sudden Aphasia in a Patient with Osteomyelitis: A Case Study
"A steak saved my life," writes columnist Damon Young, 41, in his article for GQ, as he shares the story of his diagnosis with Takayasu's arteritis. After over-indulging at dinner,…
Continue ReadingDo We Really Know Our Health Situation? A Patient with Takayasu’s Arteritis Speaks Out
In a period of unprecedented changes, it is understandable that people may question what their lives may look like moving forward. COVID-19 has now spread to 196 countries and…
Continue ReadingQuestions for COVID-19: Should Cancer Patients Attend Appointments?
In June 2019, Dicerna Pharmaceuticals submitted a clinical trial application for their DCR-A1AT therapy and expects to treat the first patient with A1AD-related liver disease near the end of…
Continue ReadingAlpha-1 Antitrypsin Deficiency Treatment Receives Orphan Drug Designation
As previously published in Scientific American, slightly after her first birthday, Emma Larson lost the use of her legs and started experiencing difficulty crawling. She was diagnosed with spinal muscular…
Continue ReadingIt Just Makes “Antisense:” Using Genetic Medicine to Treat Rare Diseases
The world is experiencing an unprecedented time in the medical realm with the rapid spread of COVID-19, a novel coronavirus. It may be difficult to understand how coronavirus may impact…
Continue ReadingThe Role of Oncology in Understanding COVID-19 and Cancer
In an interview with Medgadget, Dr. Christy Sheehy and Dr. Zachary Helft of C. Light Technologies discuss up-and-coming technologies in the diagnosis and treatment of neurological diseases such as…
Is it safe for those with autoimmune rheumatic diseases to undergo the termination of a pregnancy? According to research published in Arthritis & Rheumatology, the answer is yes. Learn more…
Continue ReadingNo Adverse Reactions between Abortion and Autoimmune Rheumatic Diseases
Researchers from the Murdoch Children’s Research Institute (MCRI) have recently discovered a previously unknown and uncharted neurodegenerative disorder. This rare disorder, which has not yet been named, affects children. It…
Continue ReadingNew Research Discovers Childhood Neurodegenerative Disorder
Because of the current global situation involving coronavirus (COVID-19), many medical organizations have canceled or postponed their annual meetings. The American Academy of Allergy, Asthma, and Immunology (AAAAI) is one…
Those diagnosed with paraganglioma-pheochromocytoma, squamous cell carcinoma of the skin (cSCC), adrenocortical carcinoma (ACC), and carcinoma of unknown primary (CUP) may soon have an additional option for treatment. According to…
Continue ReadingResearchers Find Immunotherapy Drug May Treat Pheochromocytoma
Patients with congenital diseases often experience a range of uncomfortable symptoms. On one side of the world, a family with erythromelalgia, a painful condition which can cause redness and swelling…
Continue ReadingFaulty Proteins and Failed Genes: Understanding the Biology Behind Congenital Diseases
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Sign Up For Our Patient Panel
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.